PRODUCT INFORMATION - Medsafe
HarPI060710 Page 1 of 5 PRODUCT INFORMATION NAME OF THE MEDICINE Compound Sodium Lactate (Hartmann's) Solution for …
Download PRODUCT INFORMATION - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
PRODUCT INFORMATION RINGER’S SOLUTION …
www.baxterhealthcare.com.auPI Ringer’s Solution IV infusion – 26 Mar 2015 (RSI 20120719) Page 1 of 8 PRODUCT INFORMATION RINGER’S SOLUTION FOR INTRAVENOUS INFUSION NAME OF …
Product Information Barquat PQ - Fankim
www.fankim.com21-Barquat-PQ.doc LPC-Lonza Performance Chemicals 2 (2) Version March 20, 2003 5.2 ALGAE 5.2.1 Algaestatic efficacy according to OECD 201:
Dosage and administration - Medsafe
www.medsafe.govt.nzData Sheet –New Zealand Hosp 5.0 1 DBL™ CYTARABINE INJECTION Presentation DBL™ Cytarabine Injection 20 mg/mL, 50 mg/mL and 100 mg/mL is a clear colourless sterile solution of
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.ukPage 1 of 6 Package leaflet: Information for the user Zinforo ® 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil